Nanogen Sells First NanoChip Molecular Biology Workstation to Aventis

Aventis Research & Technologies (Frankfurt, Germany) has purchased a NanoChip Molecular Biology Workstation from Nanogen Inc. (San Diego). This was Nanogen's first commercial sale of the sytem, which is used to identify and analyze test samples containing charged molecules.

Nanogen only recently began marketing its NanoChip molecular biology workstation to scientists and genomics laboratories. In beta testing at third party sites and in demonstrations at Nanogen, the NanoChip system provided comparable or better accuracy than DNA sequencing and other methods for SNP confirmation. Unlike hybridization, sequencing, and primer extension technologies, however, the NanoChip system uses electronically accelerated hybridization under very low salt conditions and no enzymes, avoiding many of the problems associated with DNA conformation and secondary structures. The system enables the user to array and analyze DNA on its NanoChip cartridges in user selected formats in a single day with walk-away automation.

For more information on the NanoChip, read NanoChip Score 100%.

Nanogen Inc. integrates microelectronics and molecular biology into a platform technology with potential commercial applications in the fields of biomedical research, genomics, medical diagnostics, genetic testing, and drug discovery.

For more information: Kieran T. Gallahue, Senior VP and CFO, Nanogen Inc., 10398 Pacific Center Ct., San Diego, CA 92121. Tel: 858-410-4600.

Edited by Jim Pomager